Primary Glioblastoma

Oncology
2
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
1
1
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

AIVITA Biomedical
1 program
1
AV-GBM-1Phase 31 trial
Active Trials
NCT05100641Not Yet RecruitingEst. Mar 2029
Laminar Pharmaceuticals
Laminar PharmaceuticalsSpain - Palma de Mallorca
1 program
1
LAM561Phase 2/31 trial
Active Trials
NCT04250922Active Not RecruitingEst. Nov 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
AIVITA BiomedicalAV-GBM-1
Laminar PharmaceuticalsLAM561

Clinical Trials (2)

NCT05100641AIVITA BiomedicalAV-GBM-1

AV-GBM-1 vs Control as Adjunctive Therapy Following Surgery and RT/TMZ in Newly Diagnosed GBM

Start: Jan 2024Est. completion: Mar 2029
Phase 3Not Yet Recruiting
NCT04250922Laminar PharmaceuticalsLAM561

LAM561 With RT and TMZ for Adults With Glioblastoma

Start: Dec 2019Est. completion: Nov 2026
Phase 2/3Active Not Recruiting

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
1h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
1h ago

Office Administrator

SystImmune
1h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
1h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
1h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
1h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 late-stage (Phase 3) programs — potential near-term approvals
2 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)